• Daclatasvir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Dihydrochloride Salt Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the active virological agent.

    Active IngredientStrengthPrimary Clinical Function
    Daclatasvir Dihydrochloride USP/Ph.Eur.60 mgThe Standard Eradication Macrodose: The definitive, globally standardized daily therapeutic payload utilized for the vast majority of patients to achieve a Sustained Virologic Response (SVR12 – Clinical Cure).
    Daclatasvir Dihydrochloride USP/Ph.Eur.30 mgThe CYP3A4 Titration Unit: The strict, mandatory dose-reduction unit utilized for patients who are co-infected with HIV and taking strong CYP3A inhibitors (like Ritonavir or Atazanavir).
    ExcipientsAnhydrous Lactose / Microcrystalline Cellulose / Croscarmellose Sodium / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film (Opadry Green)Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced dissolution-enhancing matrices to ensure the Dihydrochloride salt separates perfectly in gastric fluid, guaranteeing maximum systemic bioavailability)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 28 (Optimized exactly for a 4-week supply in strict 12-week or 24-week curative regimens).

  • Deferiprone Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, heavy-gauge HDPE bottles to ensure the absolute physical and chemical stability of the massive active pharmaceutical payload.

    Active IngredientStrengthPrimary Clinical Function
    Deferiprone USP/Ph.Eur.500 mgThe Standard Titration Unit: The baseline therapeutic dose utilized for precise, weight-based titration in pediatric and lower-weight thalassemia patients.
    Deferiprone USP/Ph.Eur.1000 mgThe Hematology Macrodose: The massive therapeutic payload required to minimize the total daily pill burden for adult patients suffering from severe, refractory iron overload.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced High-Shear Wet Granulation. Because a 1000mg tablet is inherently massive, it must be highly densified to remain swallowable, heavily coated to mask its severe bitterness, and packed with elite disintegrants to ensure it shatters instantly in the stomach)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 50 or 100 (Optimized specifically for massive, multi-pill daily chronic dispensing regimens).

  • Dolutegravir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Polymorphically Stabilized Microdose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the Dolutegravir Sodium salt.

    Active IngredientStrengthPrimary Clinical Function
    Dolutegravir (as Sodium) USP/Ph.Eur.50 mgThe Global INSTI Anchor: The definitive therapeutic payload required to force immediate, systemic viral suppression and maintain an undetectable viral load.
    ExcipientsD-Mannitol / Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Stearyl Fumarate / Premium Polymeric FilmDiluent / Binder / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing strict low-moisture granulation to prevent the active Dolutegravir Sodium from undergoing polymorphic shifts during compression, guaranteeing absolute pharmacokinetic bioequivalence)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).

  • Efavirenz ,Emtricitabine & Tenofovir Disoproxil Fumarate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Mega-Dose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles to ensure the absolute chemical survival of the moisture-sensitive Tenofovir and light-sensitive Efavirenz.

    Active IngredientStrengthPrimary Clinical Function
    Efavirenz USP/Ph.Eur.600 mgThe NNRTI Anchor: The massive, highly lipophilic non-nucleoside payload required to force immediate, systemic viral suppression.
    Emtricitabine (FTC) USP/Ph.Eur.200 mgThe Cytidine Analogue: Provides profound, long-acting intracellular viral suppression to reinforce the backbone.
    Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur.300 mgThe Nucleotide Backbone: The heavy-hitting chain terminator required to completely halt viral DNA elongation.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Hydroxypropyl Cellulose / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Binder / Surfactant / Heavy Film-Coating (Engineered utilizing High-Compression Bi-Layer Technology to fuse 1,100mg of active API into a single, aerodynamically shaped tablet that remains easy for patients to swallow, heavily coated to lock out destructive tropical humidity)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).

  • Efavirenz Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the highly lipophilic active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Efavirenz USP/Ph.Eur.600 mgThe Global NNRTI Macrodose: The massive therapeutic payload required to force immediate, systemic viral suppression when combined with a dual-NRTI backbone.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Povidone K-30 / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Surfactant / Binder / Heavy Film-Coating (Engineered specifically utilizing powerful surfactants like Sodium Lauryl Sulfate to drastically increase the solubility of the notoriously lipophilic Efavirenz molecule, ensuring rapid and complete gastrointestinal absorption)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).

  • Emtricitabine & Tenofovir Disoproxil Fumarate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the moisture-sensitive Tenofovir.

    Active IngredientStrengthPrimary Clinical Function
    Emtricitabine (FTC) USP/Ph.Eur.200 mgThe Cytidine Analogue: Provides profound, long-acting intracellular viral suppression with an exceptionally favorable safety profile.
    Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur.300 mg
    (Eq. to 245 mg Tenofovir Disoproxil)
    The Nucleotide Backbone: The heavy-hitting reverse transcriptase inhibitor required to anchor the ARV regimen and prevent viral breakthrough.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Polymeric Film (Opadry)Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing dry-granulation and heavy film-coating to protect the API from atmospheric moisture, ensuring the massive 500mg active payload remains structurally intact and easily swallowable)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).